FEZ2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.31220000315824E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.84009999995671E-06 |
Normal-vs-Stage2 |
3.203900E-04 |
Normal-vs-Stage3 |
1.85670001595639E-09 |
Normal-vs-Stage4 |
5.2340021206021E-11 |
Stage1-vs-Stage2 |
6.782000E-01 |
Stage1-vs-Stage3 |
8.258800E-03 |
Stage1-vs-Stage4 |
4.98550000005427E-06 |
Stage2-vs-Stage3 |
2.296800E-01 |
Stage2-vs-Stage4 |
3.614300E-02 |
Stage3-vs-Stage4 |
1.720830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.64509999856355E-08 |
Normal-vs-AfricanAmerican |
1.31069999964595E-07 |
Normal-vs-Asian |
1.700070E-02 |
Caucasian-vs-AfricanAmerican |
4.122200E-01 |
Caucasian-vs-Asian |
5.901200E-01 |
AfricanAmerican-vs-Asian |
8.023200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.90389999824114E-08 |
Normal-vs-Female |
2.27190000035016E-07 |
Male-vs-Female |
5.520800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.401200E-04 |
Normal-vs-Age(41-60Yrs) |
1.00409999981288E-07 |
Normal-vs-Age(61-80Yrs) |
7.09790000108512E-08 |
Normal-vs-Age(81-100Yrs) |
5.8161000000001E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.785400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.931800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.161400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.533800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.693200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.713400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.095000E-01 |
Normal-vs-Grade 2 |
1.64579999999415E-05 |
Normal-vs-Grade 3 |
3.73259978481144E-10 |
Normal-vs-Grade 4 |
1.06719966197488E-10 |
Grade 1-vs-Grade 2 |
1.936380E-01 |
Grade 1-vs-Grade 3 |
5.971400E-04 |
Grade 1-vs-Grade 4 |
5.818100E-04 |
Grade 2-vs-Grade 3 |
1.65746999999383E-05 |
Grade 2-vs-Grade 4 |
5.79130000000205E-05 |
Grade 3-vs-Grade 4 |
1.498770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.398500E-04 |
Normal-vs-ccB subtype |
2.15380047130509E-10 |
ccA subtype-vs-ccB subtype |
3.352900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.18190000009122E-08 |
Normal-vs-N1 |
4.161300E-04 |
N0-vs-N1 |
2.238600E-01 |
|
|